C-Reactive Protein-Triglyceride-Glucose Index (CTI) is an Independent Predictor of Cardiovascular Mortality in Patients with Metabolic Syndrome

Key Points

• Cardiovascular mortality is significantly predicted by the triglyceride-glucose index, a key measure of metabolic health.
• A computed risk score indicates that patients with higher CTI values face a greater risk of mortality than those with lower scores.
• Observational analysis across a cohort reveals that metabolic syndrome complications correlate with elevated CTI levels.
• Further validation is necessary to assess CTI's role as a routine prognostic marker in wider patient populations.